(2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide

C62H78N8O10 — CID 178104416

IUPAC(2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide
SMILESCCn1c(-c2cc(C#CCN3CCO[C@H](CO)C3)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1cc(O)cc(c1)C[C@H](NC(=O)[C@H](C(C)C)N(C)C(=O)[C@@H]1OCC[C@@H]1c1ccc(N)cc1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C62H78N8O10/c1-9-69-53-19-16-42-31-48(53)50(56(69)49-28-39(33-64-54(49)38(4)77-8)12-10-21-68-23-25-78-46(34-68)35-71)32-62(5,6)36-80-61(76)51-13-11-22-70(66-51)59(74)52(29-40-26-43(42)30-45(72)27-40)65-58(73)55(37(2)3)67(7)60(75)57-47(20-24-79-57)41-14-17-44(63)18-15-41/h14-19,26-28,30-31,33,37-38,46-47,51-52,55,57,66,71-72H,9,11,13,20-25,29,32,34-36,63H2,1-8H3,(H,65,73)/t38-,46-,47+,51-,52-,55-,57+/m0/s1
InChIKeyBMFJUMFMYWRHCA-YLDSFYRQSA-N
MW1095.35 g/mol
LogP6.13
Rot. Bonds12

About (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide

(2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide (PubChem CID 178104416) has the molecular formula C62H78N8O10 and a molecular weight of 1095.35 g/mol. Its IUPAC name is (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide.

Molecular Properties

Compound Name(2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide
PubChem CID178104416
Molecular FormulaC62H78N8O10
Molecular Weight1095.35 g/mol
Exact Mass1094.58
IUPAC Name(2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide
SMILESCCn1c(-c2cc(C#CCN3CCO[C@H](CO)C3)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1cc(O)cc(c1)C[C@H](NC(=O)[C@H](C(C)C)N(C)C(=O)[C@@H]1OCC[C@@H]1c1ccc(N)cc1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C62H78N8O10/c1-9-69-53-19-16-42-31-48(53)50(56(69)49-28-39(33-64-54(49)38(4)77-8)12-10-21-68-23-25-78-46(34-68)35-71)32-62(5,6)36-80-61(76)51-13-11-22-70(66-51)59(74)52(29-40-26-43(42)30-45(72)27-40)65-58(73)55(37(2)3)67(7)60(75)57-47(20-24-79-57)41-14-17-44(63)18-15-41/h14-19,26-28,30-31,33,37-38,46-47,51-52,55,57,66,71-72H,9,11,13,20-25,29,32,34-36,63H2,1-8H3,(H,65,73)/t38-,46-,47+,51-,52-,55-,57+/m0/s1
InChIKeyBMFJUMFMYWRHCA-YLDSFYRQSA-N
XLogP6.13
TPSA223.28 Ų
H-Bond Donors5
H-Bond Acceptors15
Rotatable Bonds12
Heavy Atoms80
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001095.35
LogP ≤ 56.13
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide?
The IUPAC name of (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide (CID 178104416) is (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide.
What is the SMILES notation for (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide?
The canonical SMILES for (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide is CCn1c(-c2cc(C#CCN3CCO[C@H](CO)C3)cnc2[C@H](C)OC)c2c3cc(ccc31)-c1cc(O)cc(c1)C[C@H](NC(=O)[C@H](C(C)C)N(C)C(=O)[C@@H]1OCC[C@@H]1c1ccc(N)cc1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2.
What is the InChIKey of (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide?
The InChIKey is BMFJUMFMYWRHCA-YLDSFYRQSA-N. The full InChI is InChI=1S/C62H78N8O10/c1-9-69-53-19-16-42-31-48(53)50(56(69)49-28-39(33-64-54(49)38(4)77-8)12-10-21-68-23-25-78-46(34-68)35-71)32-62(5,6)36-80-61(76)51-13-11-22-70(66-51)59(74)52(29-40-26-43(42)30-45(72)27-40)65-58(73)55(37(2)3)67(7)60(75)57-47(20-24-79-57)41-14-17-44(63)18-15-41/h14-19,26-28,30-31,33,37-38,46-47,51-52,55,57,66,71-72H,9,11,13,20-25,29,32,34-36,63H2,1-8H3,(H,65,73)/t38-,46-,47+,51-,52-,55-,57+/m0/s1.
What are the key properties of (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide?
(2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide has a molecular weight of 1095.35 g/mol, XLogP of 6.13, 12 rotatable bonds, 5 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3R)-3-(4-aminophenyl)-N-[(2S)-1-[[(8S,14S)-22-ethyl-4-hydroxy-21-[5-[3-[(2S)-2-(hydroxymethyl)morpholin-4-yl]prop-1-ynyl]-2-[(1S)-1-methoxyethyl]-3-pyridinyl]-18,18-dimethyl-9,15-dioxo-16-oxa-10,22,28-triazapentacyclo[18.5.2.12,6.110,14.023,27]nonacosa-1(26),2,4,6(29),20,23(27),24-heptaen-8-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methyloxolane-2-carboxamide is sourced from PubChem (CID 178104416), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).